Establishment of totipotency does not depend on Oct4A

Nature Cell Biology

Volumn 15, Issue 9, 2013, Pages 1089-1097

  Wu, Guangming ^a   Han, Dong ^a   Gong, Yu ^a   Sebastiano, Vittorio ^a,d   Gentile, Luca ^a   Singhal, Nishant ^a,e   Adachi, Kenjiro ^a   Fischedick, Gerrit ^a   Ortmeier, Claudia ^a   Sinn, Martina ^a   Radstaak, Martina ^a   Tomilin, Alexey ^b   Schöler, Hans R ^a,c  

^a MAX PLANCK INSTITUTE FOR MOLECULAR BIOMEDICINE   (Germany)

^b INSTITUTE OF CYTOLOGY   (Russian Federation)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; GREEN FLUORESCENT PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR NANOG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FIBROBLAST; GENE DELETION; INNER CELL MASS; LOXP SITE; MALE; MOUSE; NONHUMAN; OOCYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SOMATIC CELL; TOTIPOTENT STEM CELL; ZYGOTE;

ANIMALS; CELL LINEAGE; CELLS, CULTURED; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HOMEODOMAIN PROTEINS; MICE; MICE, KNOCKOUT; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; OOCYTES; PLURIPOTENT STEM CELLS; PREGNANCY; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TOTIPOTENT STEM CELLS;

MUS;

EID: 84883742103     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb2816     Document Type: Article

References (54)

1. Mitalipov, S. & Wolf, D. Totipotency, pluripotency and nuclear reprogramming. Adv. Biochem. Eng. Biotechnol. 114, 185-199 (2009).
2. Scholer, H. R., Hatzopoulos, A. K., Balling, R., Suzuki, N. & Gruss, P. A family of octamer-speci-c proteins present during mouse embryogenesis: evidence for germline-speci-c expression of an Oct factor. EMBO J. 8, 2543-2550 (1989).
3. Pesce, M. & Scholer, H. R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19, 271-278 (2001).
4. Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391 (1998).
5. Okumura-Nakanishi, S., Saito, M., Niwa, H. & Ishikawa, F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 280, 5307-5317 (2005).
6. Li, L., Zheng, P. & Dean, J. Maternal control of early mouse development. Development 137, 859-870 (2010).
7. Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117 (2008).
8. Rodda, D. J. et al. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 280, 24731-24737 (2005).
9. Masui, S. et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 9, 625-635 (2007).
10. Pesce, M., Marin Gomez, M., Philipsen, S. & Scholer, H. R. Binding of Sp1 and Sp3 transcription factors to the Oct-4 gene promoter. Cell Mol. Biol. 45, 709-716 (1999).
11. Jaenisch, R. & Young, R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582 (2008).
12. Kehler, J. et al. Oct4 is required for primordial germ cell survival. EMBO Rep. 5, 1078-1083 (2004).
13. Lengner, C. J. et al. Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell 1, 403-415 (2007).
14. Lee, J., Kim, H. K., Rho, J. Y., Han, Y. M. & Kim, J. The human OCT-4 isoforms differ in their ability to confer self-renewal. J. Biol. Chem. 281, 33554-33565 (2006).
15. Guo, C. L. et al. A novel variant of Oct3/4 gene in mouse embryonic stem cells. Stem Cell Res. 9, 69-76 (2012).
16. Farashahi Yazd, E. et al. OCT4B1, a novel spliced variant of OCT4, generates a stable truncated protein with a potential role in stress response. Cancer Lett. 309, 170-175 (2011).
17. Asadi, M. H. et al. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Int. J. Cancer 128, 2645-2652 (2011).
18. Zuccotti, M. et al. Maternal Oct-4 is a potential key regulator of the developmental competence of mouse oocytes. BMC Dev. Biol. 8, 97-110 (2008).
19. Foygel, K. et al. A novel and critical role for Oct4 as a regulator of the maternal-embryonic transition. Plos One 3, e4109 (2008).
20. Chambers, I. et al. Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234 (2007).
21. Yoshimizu, T. et al. Germline-speci-c expression of the Oct-4/green-uorescent protein (GFP) transgene in mice. Dev. Growth Differ. 41, 675-684 (1999).
22. Niwa, H., Miyazaki, J. & Smith, A. G. Quantitative expression of Oct-3/4 de-nes differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372-376 (2000).
23. Niwa, H. et al. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell 123, 917-929 (2005).
24. Yuan, P. et al. Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells. Genes Dev. 23, 2507-2520 (2009).
25. Dietrich, J. E. & Hiiragi, T. Stochastic patterning in the mouse pre-implantation embryo. Development 134, 4219-4231 (2007).
26. Lu, C. W. et al. Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos. Nat. Genet. 40, 921-926 (2008).
27. Blij, S., Frum, T., Akyol, A., Fearon, E. & Ralston, A. Maternal Cdx2 is dispensable for mouse development. Development 139, 3969-3972 (2012).
28. Strumpf, D. et al. Cdx2 is required for correct cell fate speci-cation and differentiation of trophectoderm in the mouse blastocyst. Development 132, 2093-2102 (2005).
29. Wu, G. et al. Initiation of trophectoderm lineage speci-cation in mouse embryos is independent of Cdx2. Development 137, 4159-4169 (2010).
30. Ralston, A. et al. Gata3 regulates trophoblast development downstream of Tead4 and in parallel to Cdx2. Development 137, 395-403 (2010).
31. Kuroda, T. et al. Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression. Mol. Cell Biol. 25, 2475-2485 (2005).
32. Szabo, P. E., Hubner, K., Scholer, H. & Mann, J. R. Allele-speci-c expression of imprinted genes in mouse migratory primordial germ cells. Mech. Dev. 115, 157-160 (2002).
33. Adachi, K. & Scholer, H. R. Directing reprogramming to pluripotency by transcription factors. Curr. Opin. Genet. Dev. 22, 1-7 (2012).
34. Heng, J. C. et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell 6, 167-174 (2010).
35. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult-broblast cultures by de-ned factors. Cell 126, 663-676 (2006).
36. Gu, P. et al. Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol. Cell Biol. 25, 3492-3505 (2005).
37. Guo, G. & Smith, A. A genome-wide screen in EpiSCs identi-es Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development 137, 3185-3192 (2010).
38. Chapman, D. L. et al. Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development. Dev. Dyn. 206, 379-390 (1996).
39. Yagi, H. et al. Role of TBX1 in human del22q11.2 syndrome. Lancet 362, 1366-1373 (2003).
40. Campbell, K. H., McWhir, J., Ritchie, W. A. & Wilmut, I. Sheep cloned by nuclear transfer from a cultured cell line. Nature 380, 64-66 (1996).
41. De Vries, W. N. et al. Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis 26, 110-112 (2000).
42. Lan, Z. J., Xu, X. & Cooney, A. J. Differential oocyte-speci-c expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice. Biol. Reprod. 71, 1469-1474 (2004).
43. El-Hashemite, N., Wells, D. & Delhanty, J. D. Single cell detection of betathalassaemia mutations using silver stained SSCP analysis: an application for preimplantation diagnosis. Mol. Hum. Reprod. 3, 693-698 (1997).
44. Hogan, B. Manipulating The Mouse Embryo : A Laboratory Manual 2nd edn (Cold Spring Harbor Laboratory Press, 1994).
45. Palmieri, S. L., Peter, W., Hess, H. & Scholer, H. R. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the-rst two extraembryonic cell lineages involved in implantation. Dev. Biol. 166, 259-267 (1994).
46. Boiani, M. et al. Variable reprogramming of the pluripotent stem cell marker Oct4 in mouse clones: distinct developmental potentials in different culture environments. Stem Cells 23, 1089-1104 (2005).
47. Ho, Y., Wigglesworth, K., Eppig, J. J. & Schultz, R. M. Preimplantation development of mouse embryos in KSOM: augmentation by amino acids and analysis of gene expression. Mol. Reprod. Dev. 41, 232-238 (1995).
48. Nagy, A. Manipulating The Mouse Embryo : A Laboratory Manual 3rd edn (Cold Spring Harbor Laboratory Press, 2003).
49. Long, J. Z., Lackan, C. S. & Hadjantonakis, A. K. Genetic and spectrally distinct in vivo imaging: embryonic stem cells and mice with widespread expression of a monomeric red-uorescent protein. BMC Biotechnol. 5, 20-30 (2005).
50. Tachibana, M. et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 461, 367-372 (2009).
51. Bryja, V., Bonilla, S. & Arenas, E. Derivation of mouse embryonic stem cells. Nat. Protoc. 1, 2082-2087 (2006).
52. Kim, J. B. et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454, 646-650 (2008).
53. Wu, G. et al. Ef-cient derivation of pluripotent stem cells from siRNA-mediated Cdx2-de-cient mouse embryos. Stem Cells Dev. 20, 485-493 (2011).
54. Wu, G. et al. Generation of healthy mice from gene-corrected disease-speci-c induced pluripotent stem cells. PLoS Biol. 9, e1001099 (2011).